Glint Pharmaceuticals Announces Formation of Clinical Advisory Board

UF startup Glint Pharmaceuticals, an ophthalmic pharmaceutical company that delivers medicated contact lenses to treat eye diseases, announces the formation of a clinical advisory board composed of notable and experienced clinicians in ophthalmology and optometry.

The clinicians on the advisory board include Dr. Mark Abelson, founder of ORA, Inc.; Dr. Cynthia Matossian, medical director at Matossian Eye Associates, an affiliate of Prism Vision Group; Dr. James Thimons, medical director at Ophthalmic Consultants of Connecticut; Dr. Mark Blecher, professor of ophthalmology at Wills Eye Hospital; and Dr. Paul Karpecki, director at Kentucky Eye Institute.

Learn more about Glint Pharmaceuticals Announces Formation of Clinical Advisory Board.